OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
285130$44150.0059

SK Chemicals Co Ltd

Commodity ChemicalsVerified

SK Chemicals has a market price of 44,150 KRW per share, with a market capitalization of 762.42 billion KRW. The company's price-to-earnings ratio is 17.08, and its price-to-book ratio is 0.34, indicating that the company is trading at a discount relative to its book value. The enterprise value to EBITDA ratio is negative at -11,368.03, reflecting the company's operating loss of 207.36 million KRW. The company's profitability is weak, with a return on equity of 1.98% and a return on assets of 0.73%. These figures are below the industry median for commodity chemicals, which typically exhibit higher returns due to the capital-intensive nature of the industry. The company's operating income is negative, and its net income is 44.65 billion KRW, which is a modest profit given the scale of its operations. SK Chemicals' revenue is concentrated in a few key segments, with the majority of its revenue derived from the production and sale of commodity chemicals. The company's geographic exposure is primarily within South Korea, with limited international operations. This concentration increases the company's vulnerability to domestic economic conditions and regulatory changes. The company's growth trajectory is mixed. While it has a positive operating cash flow of 235.91 billion KRW, its free cash flow is negative at -273.51 billion KRW, indicating that the company is investing heavily in capital expenditures. The company's capital expenditure of -466.4 billion KRW suggests a significant investment in infrastructure and expansion. However, the company's revenue growth is not specified in the provided data. The company faces several risk factors, including liquidity concerns. The company's liquidity risk is rated as medium, and its dilution risk is low. The company has a debt-to-equity ratio of 0.96, indicating a relatively balanced capital structure. However, the company's net cash position is negative after subtracting total debt, which could pose a challenge in the event of a liquidity crunch. The company's dilution potential is low, and no significant adjustments have been applied to its valuation metrics. Recent events and filings indicate that the company is under analyst scrutiny. The mean price target for SK Chemicals is 93,000 KRW, with a median price target of the same amount. The mean recommendation from analysts is 1.50, indicating a generally positive outlook. However, the company has received one strong-buy and one buy recommendation, with no hold recommendations, suggesting a cautious but optimistic view from the analyst community.

30-day price · 285130-8100.00 (-15.8%)
Low$42950.00High$62500.00Close$43300.00As of20 May, 00:00 UTC
Profile
CompanySK Chemicals Co Ltd
Ticker285130.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. SK Chemicals Co Ltd is a South Korean company engaged in the production and sale of commodity chemicals, primarily serving the petrochemical and industrial sectors.

Classification. SK Chemicals is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

SK Chemicals has a market price of 44,150 KRW per share, with a market capitalization of 762.42 billion KRW. The company's price-to-earnings ratio is 17.08, and its price-to-book ratio is 0.34, indicating that the company is trading at a discount relative to its book value. The enterprise value to EBITDA ratio is negative at -11,368.03, reflecting the company's operating loss of 207.36 million KRW. The company's profitability is weak, with a return on equity of 1.98% and a return on assets of 0.73%. These figures are below the industry median for commodity chemicals, which typically exhibit higher returns due to the capital-intensive nature of the industry. The company's operating income is negative, and its net income is 44.65 billion KRW, which is a modest profit given the scale of its operations. SK Chemicals' revenue is concentrated in a few key segments, with the majority of its revenue derived from the production and sale of commodity chemicals. The company's geographic exposure is primarily within South Korea, with limited international operations. This concentration increases the company's vulnerability to domestic economic conditions and regulatory changes. The company's growth trajectory is mixed. While it has a positive operating cash flow of 235.91 billion KRW, its free cash flow is negative at -273.51 billion KRW, indicating that the company is investing heavily in capital expenditures. The company's capital expenditure of -466.4 billion KRW suggests a significant investment in infrastructure and expansion. However, the company's revenue growth is not specified in the provided data. The company faces several risk factors, including liquidity concerns. The company's liquidity risk is rated as medium, and its dilution risk is low. The company has a debt-to-equity ratio of 0.96, indicating a relatively balanced capital structure. However, the company's net cash position is negative after subtracting total debt, which could pose a challenge in the event of a liquidity crunch. The company's dilution potential is low, and no significant adjustments have been applied to its valuation metrics. Recent events and filings indicate that the company is under analyst scrutiny. The mean price target for SK Chemicals is 93,000 KRW, with a median price target of the same amount. The mean recommendation from analysts is 1.50, indicating a generally positive outlook. However, the company has received one strong-buy and one buy recommendation, with no hold recommendations, suggesting a cautious but optimistic view from the analyst community.
Key takeaways
  • SK Chemicals is trading at a discount to book value, with a price-to-book ratio of 0.34.
  • The company's profitability is weak, with a return on equity of 1.98% and a return on assets of 0.73%.
  • The company's capital structure is relatively balanced, with a debt-to-equity ratio of 0.96.
  • SK Chemicals is investing heavily in capital expenditures, with a negative free cash flow of -273.51 billion KRW.
  • The company faces liquidity concerns, with a medium liquidity risk rating and a negative net cash position after subtracting total debt.
  • Analysts have a generally positive outlook on the company, with a mean price target of 93,000 KRW and a mean recommendation of 1.50.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$2.37T
Gross profit$499.11B
Operating income-$207.4M
Net income$44.65B
R&D
SG&A
D&A
SBC
Operating cash flow$235.91B
CapEx-$466.40B
Free cash flow-$273.51B
Total assets$6.09T
Total liabilities$3.83T
Total equity$2.26T
Cash & equivalents$567.55B
Long-term debt$2.16T
Valuation
Market price$44150.00
Market cap$762.42B
Enterprise value$2.36T
P/E17.1
Reported non-GAAP P/E
EV/Revenue1.0
EV/Op income
EV/OCF10.0
P/B0.3
P/Tangible book0.3
Tangible book$2.26T
Net cash-$1.59T
Current ratio2.2
Debt/Equity1.0
ROA0.7%
ROE2.0%
Cash conversion5.3%
CapEx/Revenue-19.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric285130Activity
Op margin-0.0%0.4% medp25 -8.0% · p75 16.0%below median
Net margin1.9%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin21.1%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-19.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity96.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target93,000.00 KRW
Median price target93,000.00 KRW
High price target93,000.00 KRW
Low price target93,000.00 KRW
Mean recommendation1.50 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate5,205.00 KRW
Last actual EPS2,313.04 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 00:46 UTCJob: 7e19a9da